Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo
NCT01203189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2017-11-06
Summary
The aims of this study are to compare the effectiveness of antifungal foam versus antifungal shampoo and determine patient compliance and satisfaction with both vehicles among African American females with dandruff practicing less than once weekly hair washing.
Conditions
- Seborrheic Dermatitis
Interventions
- DRUG
-
ketoconazole 2% foam
Subjects in the Foam (F) group will apply ketoconazole 2% foam to the scalp twice daily for four weeks.
- DRUG
-
ketoconazole 2% shampoo
Subjects in the Shampoo (S) group will wash their hair twice weekly for four weeks with ketoconazole 2% shampoo.
Sponsors & Collaborators
-
St. Louis University
lead OTHER
Principal Investigators
-
Aibing M Guo, M.D. · St. Louis University Dermatology
-
Scott W Fosko, M.D. · St. Louis University Dermatology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers
NCT01690286 ·Status: COMPLETED ·Phase: PHASE1
-
Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis
NCT03688971 ·Status: UNKNOWN ·Phase: PHASE2
-
An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot
NCT01110330 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis
NCT00565279 ·Status: COMPLETED ·Phase: PHASE3
-
Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis
NCT02606383 ·Status: WITHDRAWN ·Phase: PHASE3
-
STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%
NCT00703846 ·Status: COMPLETED ·Phase: PHASE4
-
Ketoconazole Foam 2% for the Treatment of Versicolor
NCT00830388 ·Status: COMPLETED ·Phase: PHASE4
-
GSK239512 DDI Study
NCT01802931 ·Status: COMPLETED ·Phase: PHASE1
-
The Comparative Assessment of Mycological Efficacy, Safety, Recurrence, and Cost-effectiveness of Selenium Sulfide 1.8% Shampoo Versus Ketoconazole 2% Shampoo in Pityriasis Versicolor: a Double-blind Randomized Controlled Trial
NCT04007237 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax).
NCT01021358 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug Interaction Study of JNJ-31001074 and Ketoconazole in Healthy Volunteers
NCT00915746 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis
NCT06400056 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606
NCT00434486 ·Status: COMPLETED ·Phase: PHASE1
-
Non-inferiority Trial of Dapaconazole Versus Ketoconazole
NCT03320486 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis
NCT03824912 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoconazole on the Pharmacokinetics of the GDC-0941 Tablet
NCT01240226 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects
NCT01910480 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
NCT01473316 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects
NCT01468714 ·Status: COMPLETED ·Phase: PHASE1
-
Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash
NCT03471364 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823
NCT01189175 ·Status: COMPLETED ·Phase: PHASE1
-
A Therapeutic Equivalence Study of Ketoconazole Cream 2%
NCT04203342 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)
NCT01114191 ·Status: COMPLETED ·Phase: PHASE1
-
Alternation in the Human Microbiome With Commonly Used Topical Medications
NCT03437005 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis
NCT02824926 ·Status: COMPLETED ·Phase: PHASE2